Ascentage Pharma's Series A Round

Ascentage Pharma raised a round of funding on August 12, 2015.

Ascentage Pharma is an innovative small-molecule oncology pharma headquartered in Shangha. Ascentage has seven drug programs aimed at six drug targets, three of them clinical-stage.…

Articles about Ascentage Pharma's Series A Round: